Answers are grounded in this paper and cite their sources.
A first report of a major condition in a longitudinal survey is not the same as clinical onset or diagnosis. After that survey-recognition point, reduced activities of daily living (ADL)-independent time can reflect survival with ADL limitation or time not alive. We compared condition-specific five-year time in these three states. We used harmonized data from the Health and Retirement Study, Survey of Health, Ageing and Retirement in Europe, China Health and Retirement Longitudinal Study, and Korean Longitudinal Study of Aging. Eligible adults were aged 65 years or older and had a first observed survey report of cardiac disease, stroke, cancer, chronic respiratory disease, or, as a secondary heterogeneous category, co-reported multiple conditions. A reversible continuous-time multistate model estimated transitions between ADL independence and limitation and from either living state to death. Five-year state time was standardized to answer how outcomes would differ if each condition were reported in a population with the same age, sex, cohort, pre-report ADL, and index ADL distributions. Among 13,954 eligible episodes, 11,129 (79.75%) contributed informative post-index observation. Expected ADL-independent time ranged from 33.3 to 38.3 months across standardized condition scenarios. In a post hoc interpretive comparison, stroke and cancer had 34.6 and 36.7 independent months, respectively. Stroke was associated with 6.13 more ADL-limited months (95% confidence interval [CI], 5.05 to 7.62) and 4.03 fewer months not alive (95% CI, 2.96 to 5.07 fewer) than cancer. A two-period time structure and a common-five-item ADL sensitivity analysis preserved these directions and magnitudes. Following first observed survey reports, major-condition groups differed in the division of non-independent time between living with ADL limitation and time not alive. These population-average standardized estimates describe post-report state-occupation patterns from survey recognition, not from clinical onset, and do not provide individual prognosis.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: